Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06266624

Tourniquet-Test in HHT

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
92 (actual)
Sponsor
University Hospital, Essen · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The Tourniquet test is used as a diagnostic procedure for thrombocytopathies and vascular diseases. Currently, there is no evidence whether this test is also positive in hereditary haemorrhagic telangiectasia (HHT), a vasculopathy. The aim of this study was to investigate whether this non-invasive test could also be used as an additional diagnostic criterion in patients with HHT.

Detailed description

The Tourniquet test is used as a diagnostic procedure for thrombocytopathies and vascular diseases. Currently, there is no evidence whether this test is also positive in hereditary haemorrhagic telangiectasia (HHT), a vasculopathy. The aim of this study was to investigate whether this non-invasive test could also be used as an additional diagnostic criterion in patients with HHT.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTTourniquet TestTourniquet Test was performed in patients with HHT

Timeline

Start date
2020-09-25
Primary completion
2023-07-30
Completion
2025-07-30
First posted
2024-02-20
Last updated
2024-12-10

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT06266624. Inclusion in this directory is not an endorsement.